VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapy
(MedPage Today) -- TAMPA, Fla. -- As lines of therapy increased for recurrent ovarian cancer, so did the risk of venous thromboembolism (VTE), a retrospective study showed.
Almost 80% of VTEs occurred in patients who had received three or more...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | Heart | Ovarian Cancer | Ovaries | Study | Thrombosis